Cargando…
Establishing Classifiers With Clinical Laboratory Indicators to Distinguish COVID-19 From Community-Acquired Pneumonia: Retrospective Cohort Study
BACKGROUND: The initial symptoms of patients with COVID-19 are very much like those of patients with community-acquired pneumonia (CAP); it is difficult to distinguish COVID-19 from CAP with clinical symptoms and imaging examination. OBJECTIVE: The objective of our study was to construct an effectiv...
Autores principales: | Dai, Wanfa, Ke, Pei-Feng, Li, Zhen-Zhen, Zhuang, Qi-Zhen, Huang, Wei, Wang, Yi, Xiong, Yujuan, Huang, Xian-Zhang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JMIR Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7901596/ https://www.ncbi.nlm.nih.gov/pubmed/33534722 http://dx.doi.org/10.2196/23390 |
Ejemplares similares
-
Clinical and laboratory features distinguishing pandemic H1N1 influenza-related pneumonia from interpandemic community-acquired pneumonia in adults
por: Bewick, Thomas, et al.
Publicado: (2011) -
Distinguishing between productive and abortive promoters using a random forest classifier in Mycoplasma pneumoniae
por: Lloréns-Rico, Verónica, et al.
Publicado: (2015) -
Artificial Intelligence Distinguishes COVID-19 from Community Acquired Pneumonia on Chest CT
por: Li, Lin, et al.
Publicado: (2020) -
Identification of Serum miRNAs as Effective Diagnostic Biomarkers for Distinguishing Primary Central Nervous System Lymphoma from Glioma
por: Si, Pei-pei, et al.
Publicado: (2022) -
Heparin-binding protein and procalcitonin in the diagnosis of pathogens causing community-acquired pneumonia in adult patients: a retrospective study
por: Cai, Rentian, et al.
Publicado: (2021)